Intracellular Delivery via Noncharged Sequence-Defined Cell

(19,20) Treatment with NaN3 and DOG resulted in a slight reduction of PEO2–B uptake in HeLa and SKOV-3 cells and no reduction in HEK293 cells (Figur...
0 downloads 0 Views 1021KB Size
Subscriber access provided by FORDHAM UNIVERSITY

Article

Intracellular Delivery via Non-Charged Sequence-Defined Cell-Penetrating Oligomers Ngoc Nhu Phan, Connie Li, and Christopher A. Alabi Bioconjugate Chem., Just Accepted Manuscript • DOI: 10.1021/acs.bioconjchem.8b00336 • Publication Date (Web): 28 Jun 2018 Downloaded from http://pubs.acs.org on June 30, 2018

Just Accepted “Just Accepted” manuscripts have been peer-reviewed and accepted for publication. They are posted online prior to technical editing, formatting for publication and author proofing. The American Chemical Society provides “Just Accepted” as a service to the research community to expedite the dissemination of scientific material as soon as possible after acceptance. “Just Accepted” manuscripts appear in full in PDF format accompanied by an HTML abstract. “Just Accepted” manuscripts have been fully peer reviewed, but should not be considered the official version of record. They are citable by the Digital Object Identifier (DOI®). “Just Accepted” is an optional service offered to authors. Therefore, the “Just Accepted” Web site may not include all articles that will be published in the journal. After a manuscript is technically edited and formatted, it will be removed from the “Just Accepted” Web site and published as an ASAP article. Note that technical editing may introduce minor changes to the manuscript text and/or graphics which could affect content, and all legal disclaimers and ethical guidelines that apply to the journal pertain. ACS cannot be held responsible for errors or consequences arising from the use of information contained in these “Just Accepted” manuscripts.

is published by the American Chemical Society. 1155 Sixteenth Street N.W., Washington, DC 20036 Published by American Chemical Society. Copyright © American Chemical Society. However, no copyright claim is made to original U.S. Government works, or works produced by employees of any Commonwealth realm Crown government in the course of their duties.

Page 1 of 6 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Bioconjugate Chemistry

Scheme 1. Synthetic methodology utilized for the assembly of sequence-defined oligoTEAs. OligoTEAs are assembled with a series of iterative thiol-ene and thiol-Michael additions interspersed with fluorous solid phase purifications (FSPE). 1299x639mm (72 x 72 DPI)

ACS Paragon Plus Environment

Bioconjugate Chemistry 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Figure 1. (A) Cellular uptake of fluorescein cargo by oligoTEAs in HeLa cells measured by flow cytometry. Cells were treated with 5 µM of fluorescein-oligoTEA conjugates for 1 hour. (B) Live-cell confocal microscopy of fluorescein cargo uptake by PEO2-B and R9 in HeLa cells. Images are the merged green fluorescence of the fluorescein-oligoTEA conjugates and the bright field image of the cell. (C) Cellular uptake of Atto-488PEO2-B (5 µM, 1 hour) in HeLa cells. Cells were treated with a trypan blue solution for cell surface quenching prior to data acquisition. (D) Cellular uptake of PEO2-B in HeLa, SKOV-3 and HEK293 cells measured by flow cytometry. All cells were treated with 5 µM of PEO2-B-fluorescein conjugates for 1 hour. (E) Dose-dependent uptake of PEO2-B in HeLa cells. (F) Uptake kinetics of fluorescein-PEO2-B at 2.5 µM in HeLa cells via flow cytometry.

ACS Paragon Plus Environment

Page 2 of 6

Page 3 of 6 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Bioconjugate Chemistry

Figure 2. (A) Cellular uptake of PEO2-B and R9 conjugates in HeLa cells with and without serum. (B) Cellular uptake of PEO2-B and R9 in HeLa cells with and without heparin pretreatment at the indicated doses. 230x101mm (300 x 300 DPI)

ACS Paragon Plus Environment

Bioconjugate Chemistry 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Figure 3. Temperature-dependent cellular uptake of (A) PEO2-B and (B) R9 in HeLa, SKOV-3 and HEK293 cells. Effect of endocytosis inhibitors on cellular uptake of (C) PEO2-B and (D) R9 in HeLa, SKOV-3 and HEK293 cells. Cells were pre-treated with chlorpromazine to inhibit clathrin, filipin III to inhibit caveolae, cytochalasin D to inhibit macropinocytosis, and NaN3/2-deoxy-D-glucose to block ATP synthesis. 236x182mm (300 x 300 DPI)

ACS Paragon Plus Environment

Page 4 of 6

Page 5 of 6 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Bioconjugate Chemistry

Figure 4. Membrane fluidity reflected by the Laurdan GP values of HeLa, SKOV-3 and HEK293 cells. 93x101mm (300 x 300 DPI)

ACS Paragon Plus Environment

Bioconjugate Chemistry 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Figure 5. Confocal microscopy of fluorescein-PEO2-B (green) co-delivered with (A) Transferrin-AlexaFluor 647, (B) Dextran-AlexaFluor 647, and (C) LysoTracker Deep Red. The nuclei are stained blue with Hoescht 33342 at 40X magnification. 778x777mm (72 x 72 DPI)

ACS Paragon Plus Environment

Page 6 of 6